Literature DB >> 15249655

Met provides essential signals for liver regeneration.

Malgorzata Borowiak1, Alistair N Garratt, Torsten Wüstefeld, Michael Strehle, Christian Trautwein, Carmen Birchmeier.   

Abstract

Genetic analysis in mice has demonstrated a crucial role of the Met tyrosine kinase receptor and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), in development of the liver, muscle, and placenta. Here, we use conditional mutagenesis in mice to analyze the function of Met during liver regeneration, using the Mx-cre transgene to introduce the mutation in the adult. After partial hepatectomy in mice carrying the Mx-cre-induced Met mutation, regeneration of the liver is impaired. Comparison of signal transduction pathways in control and mutant livers indicates that Met and other signaling receptors cooperate to fully activate particular signaling molecules, for instance, the protein kinase Akt. However, activation of the Erk1/2 kinase during liver regeneration depends exclusively on Met. Signaling crosstalk is thus an important aspect of the regulation of liver regeneration. Analysis of cell cycle progression of hepatocytes in conditional Met mutant mice indicates a defective exit from quiescence and diminished entry into S phase. Impaired liver regeneration is accompanied by compensatory physiological responses that include prolonged up-regulation of HGF/SF and IL-6 in peripheral blood. Our data demonstrate that the HGF/SF/Met signaling system is essential not only during liver development but also for the regeneration of the organ in the adult.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249655      PMCID: PMC490025          DOI: 10.1073/pnas.0403412101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Sibling rivalry in the E2F family.

Authors:  Jeffrey M Trimarchi; Jacqueline A Lees
Journal:  Nat Rev Mol Cell Biol       Date:  2002-01       Impact factor: 94.444

2.  Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.

Authors:  Rejane Paumelle; David Tulasne; Zoulika Kherrouche; Serge Plaza; Catherine Leroy; Sylvie Reveneau; Bernard Vandenbunder; Veronique Fafeur; David Tulashe; Syline Reveneau
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

3.  STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration.

Authors:  Wei Li; Xianping Liang; Christoph Kellendonk; Valeria Poli; Rebecca Taub
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

4.  Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats.

Authors:  Christian Picard; Luc Lambotte; Peter Starkel; Christine Sempoux; Alain Saliez; Véronique Van den Berge; Yves Horsmans
Journal:  J Hepatol       Date:  2002-05       Impact factor: 25.083

5.  Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver.

Authors:  Axel Behrens; Maria Sibilia; Jean-Pierre David; Uta Möhle-Steinlein; François Tronche; Günther Schütz; Erwin F Wagner
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

Review 6.  Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases.

Authors:  K Matsumoto; T Nakamura
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

7.  Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

Authors:  T Nakamura; S Mizuno; K Matsumoto; Y Sawa; H Matsuda; T Nakamura
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

8.  Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.

Authors:  Hongkui Jin; Renhui Yang; Wei Li; Annie K Ogasawara; Ralph Schwall; David A Eberhard; Zhong Zheng; David Kahn; Nicholas F Paoni
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

9.  STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers.

Authors:  Michael Torbenson; Shi Qi Yang; Hui Zhi Liu; Jiawen Huang; Wesley Gage; Anna Mae Diehl
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy.

Authors:  T Sakamoto; Z Liu; N Murase; T Ezure; S Yokomuro; V Poli; A J Demetris
Journal:  Hepatology       Date:  1999-02       Impact factor: 17.425

View more
  180 in total

Review 1.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

2.  The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice.

Authors:  Tolunay Beker Aydemir; Harry S Sitren; Robert J Cousins
Journal:  Gastroenterology       Date:  2012-02-25       Impact factor: 22.682

Review 3.  Gene therapy for liver regeneration: experimental studies and prospects for clinical trials.

Authors:  Hussein-M Atta
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

4.  Growth factor- and cytokine-driven pathways governing liver stemness and differentiation.

Authors:  Aránzazu Sánchez; Isabel Fabregat
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  New concepts in liver regeneration.

Authors:  Kimberly J Riehle; Yock Y Dan; Jean S Campbell; Nelson Fausto
Journal:  J Gastroenterol Hepatol       Date:  2011-01       Impact factor: 4.029

6.  Combined systemic elimination of MET and epidermal growth factor receptor signaling completely abolishes liver regeneration and leads to liver decompensation.

Authors:  Shirish Paranjpe; William C Bowen; Wendy M Mars; Anne Orr; Meagan M Haynes; Marie C DeFrances; Silvia Liu; George C Tseng; Anastasia Tsagianni; George K Michalopoulos
Journal:  Hepatology       Date:  2016-10-01       Impact factor: 17.425

Review 7.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

8.  Evidence for LKB1/AMP-activated protein kinase/ endothelial nitric oxide synthase cascade regulated by hepatocyte growth factor, S-adenosylmethionine, and nitric oxide in hepatocyte proliferation.

Authors:  Mercedes Vázquez-Chantada; Usue Ariz; Marta Varela-Rey; Nieves Embade; Nuria Martínez-Lopez; David Fernández-Ramos; Laura Gómez-Santos; Santiago Lamas; Shelly C Lu; M Luz Martínez-Chantar; José M Mato
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

Review 9.  Targeting the HGF/c-MET pathway in hepatocellular carcinoma.

Authors:  Lipika Goyal; Mandar D Muzumdar; Andrew X Zhu
Journal:  Clin Cancer Res       Date:  2013-02-06       Impact factor: 12.531

10.  Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.

Authors:  Veena Sangwan; Grigorios N Paliouras; Jasmine V Abella; Nadia Dubé; Anie Monast; Michel L Tremblay; Morag Park
Journal:  J Biol Chem       Date:  2008-09-26       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.